Details of the Drug

General Information of Drug (ID: DMZJTSP)

• Drug Name: US9409892, 148
• Synonyms: CHEMBL3893184; SCHEMBL15268628; BDBM241053; US9409892, 148
• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 368.4
  Logarithm of the Partition Coefficient (xlogp); 3.5
  Rotatable Bond Count (rotbonds); 6
  Hydrogen Bond Donor Count (hbonddonor); 3
  Hydrogen Bond Acceptor Count (hbondacc); 6
• Chemical Identifiers:
  Formula: C20H17FN2O4
  IUPAC Name: 4-[[7-(4-fluorophenyl)-4-hydroxyisoquinoline-3-carbonyl]amino]butanoic acid
  Canonical SMILES: C1=CC(=CC=C1C2=CC3=CN=C(C(=C3C=C2)O)C(=O)NCCCC(=O)O)F
  InChI: InChI=1S/C20H17FN2O4/c21-15-6-3-12(4-7-15)13-5-8-16-14(10-13)11-23-18(19(16)26)20(27)22-9-1-2-17(24)25/h3-8,10-11,26H,1-2,9H2,(H,22,27)(H,24,25)
  InChIKey: ZCPXHSRUGVQBOS-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 71736440
  TTD ID: D0SM8Z

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HIF-prolyl hydroxylase 2 (HPH-2)	TT9ISBX	EGLN1_HUMAN	Inhibitor	[1]

References

• [1] 4-hydroxy-isoquinoline compounds as HIF hydroxylase inhibitors. US9409892.